Cite
HARVARD Citation
Dreaden, E. et al. (2018). RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors. Bioengineering & translational medicine. 3 (1), pp. 26-36. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dreaden, E. et al. (2018). RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors. Bioengineering & translational medicine. 3 (1), pp. 26-36. [Online].